相关实验视频

Updated: Jul 15, 2025

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

Published on: January 2, 2015

在神经退行性疾病中,对病理性蛋白进行诊断和治疗向

Naruhiko Sahara¹, Makoto Higuchi¹

¹Department of Functional Brain Imaging, Institute for Quantum Medical Sciences, National Institutes for Quantum Science and Technology, Chiba, Japan.

|September 25, 2023

概括

陶氏症涉及陶氏蛋白质的积累,导致认知能力下降. 研究探讨了像PM-PBB3成像等诊断工具和针对清除和神经炎症的治疗策略.

科学领域:

神经科学是一个神经科学.
神经病理学神经病理学
分子生物学分子生物学

背景情况:

病是一种神经退行性疾病,由异常的蛋白聚合定义.
神经纤维质病变与认知缺陷相关,但机制尚不清楚.
低温电子显微镜揭示了多种多样的丝结构,有助于病症的分类.

研究的目的:

审查目前对病的诊断和治疗药物.
突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出
讨论潜在的策略,以针对病理性鱼物种.

主要方法:

关于病的最新研究的综述.
对丝结构的冷电子显微镜发现的分析.
评估体内tau成像技术,包括PM-PBB3PET追踪器.

主要成果:

丝结构各有不同,使得病症的分类成为可能.
PM-PBB3 PET 标记器可提供高对比度图像的陶沉积物.
潜在的治疗策略包括增强tau降解和非细胞自主清除.
神经炎症生物标志物是了解质细胞作用所必需的.

结论:

冷-EM和PET成像技术的进步改善了病的诊断.
针对tau降解和神经元-质网络提供了治疗潜力.
对神经炎症的进一步研究对于开发有效的治疗方法至关重要.

关键词:

改变疾病的疗法.神经成像是一种神经成像.淘宝PET 淘宝PET 淘宝陶丝是陶丝的组成部分.病症是一种病症.

更多相关视频

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia

Published on: November 9, 2018

An In Vitro Model for Studying Tau Aggregation Using Lentiviral-mediated Transduction of Human Neurons

An In Vitro Model for Studying Tau Aggregation Using Lentiviral-mediated Transduction of Human Neurons

Published on: May 23, 2019

相关概念视频

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...